Quantum-Si (NASDAQ:QSI) Insider Sells $28,066.56 in Stock

Quantum-Si Incorporated (NASDAQ:QSI) insider John Vieceli sold 21,927 shares of the firm’s stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total transaction of $28,066.56. Following the transaction, the insider directly owned 800,973 shares of the company’s stock, valued at $1,025,245.44. This represents a 2.66% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Quantum-Si Stock Up 5.3%

Shares of QSI opened at $1.30 on Thursday. The stock has a market cap of $279.06 million, a P/E ratio of -1.93 and a beta of 2.96. The business’s 50 day moving average price is $1.61 and its 200-day moving average price is $1.58. Quantum-Si Incorporated has a 52 week low of $0.95 and a 52 week high of $5.77.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings data on Wednesday, November 5th. The company reported ($0.17) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.17). Quantum-Si had a negative return on equity of 47.90% and a negative net margin of 3,677.97%.The business had revenue of $0.55 million during the quarter, compared to analysts’ expectations of $0.60 million. On average, equities analysts anticipate that Quantum-Si Incorporated will post -0.65 EPS for the current year.

Institutional Trading of Quantum-Si

A number of institutional investors have recently made changes to their positions in QSI. Charles Schwab Investment Management Inc. raised its holdings in shares of Quantum-Si by 19.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 367,444 shares of the company’s stock valued at $441,000 after purchasing an additional 59,423 shares during the last quarter. Deutsche Bank AG lifted its holdings in shares of Quantum-Si by 107.4% during the 1st quarter. Deutsche Bank AG now owns 67,522 shares of the company’s stock valued at $81,000 after buying an additional 34,962 shares during the period. Invesco Ltd. boosted its stake in shares of Quantum-Si by 177.7% in the 1st quarter. Invesco Ltd. now owns 103,657 shares of the company’s stock worth $124,000 after buying an additional 66,336 shares during the last quarter. Nuveen LLC bought a new stake in shares of Quantum-Si in the first quarter worth $383,000. Finally, Russell Investments Group Ltd. increased its position in Quantum-Si by 322.6% during the first quarter. Russell Investments Group Ltd. now owns 38,257 shares of the company’s stock valued at $46,000 after acquiring an additional 29,204 shares during the last quarter. Hedge funds and other institutional investors own 39.90% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on QSI. Weiss Ratings reissued a “sell (d-)” rating on shares of Quantum-Si in a research report on Monday. Canaccord Genuity Group cut their price target on shares of Quantum-Si from $2.00 to $1.50 and set a “hold” rating on the stock in a report on Monday. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $3.60.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.